share_log

HC Wainwright & Co. Reiterates Buy on Lumos Pharma, Maintains $28 Price Target

Benzinga ·  Aug 10, 2023 06:35

HC Wainwright & Co. analyst Edward White reiterates Lumos Pharma (NASDAQ:LUMO) with a Buy and maintains $28 price target.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment